Atara Biotherapeutics Inc - Company Profile
Powered by 
All the sales intelligence you need on Atara Biotherapeutics Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Atara Biotherapeutics Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Atara Biotherapeutics Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
View up-to-date information on Atara Biotherapeutics Inc patents, including inventor and filing insights.
Patent Trends
| Publication Identifier | Document Type | Title | Classification-CPC | Publication Date |
|---|---|---|---|---|
| JP2023099685A | Application | Methods for managing tumor flare in adoptive immunotherapy | C12N2710/16234; A61K2039/5158; A61K2039/545; A61K2039/585; A61K31/00; A61K35/17; A61K39/0011; A61K39/12; A61P35/00 | July 13, 2023 |
| US20230201231A1 | Application | Administration of an anti-activin-a compound to a subject | A61K2039/505; A61K2039/545; A61K31/704; A61K31/7068; A61K38/177; A61K38/1796; A61K39/3955; A61K39/39558; A61K45/06; A61P15/00; A61P35/00; A61P43/00; C07K16/22; C07K2317/76 | June 29, 2023 |
| EP3962955A4 | Search Report | Antigenspezifische gegen cd19 gerichtete car-t-zellen | C12N2510/00; C12N5/0636; A61K2039/505; A61K2039/5156; A61K2039/5158; A61K31/7088; A61K35/15; A61K35/17; A61K38/00; A61P35/00; A61P35/02; C07K14/7051; C07K14/70517; C07K14/70521; C07K14/70578; C07K16/2803; C07K2317/31; C07K2317/622; C07K2317/76; C07K2319/02; C07K2319/03; C07K2319/33; Y02A50/30 | May 24, 2023 |
| EP4126043A1 | Application | Chimäre antigenrezeptorpolypeptide und zugehörige immunmodulatorische zellen zur behandlung von aspergillose | A61K2039/505; A61K38/00; C07K14/7051; C07K16/14; C07K2317/20; C07K2317/21; C07K2317/24; C07K2317/54; C07K2317/55; C07K2317/56; C07K2319/03; G01N2333/38; G01N2400/32; G01N2800/26; G01N33/56961; Y02A50/30 | February 08, 2023 |
| US20230010255A1 | Application | Car t cells that target aspergillus-associated antigens | A61K2039/5156; A61K2039/5158; A61K35/17; A61K38/00; A61K39/0002; A61P31/10; C07K14/705; C07K14/7051; C07K14/70517; C07K14/70521; C07K16/14; C07K2319/03; Y02A50/30 | January 12, 2023 |
Top Inventors by Filings (Count by publication)
| Name | Count |
|---|
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer